Literature DB >> 16783497

Family-based study of markers at the 5'-flanking region of the human dopamine transporter gene reveals potential association with schizophrenic psychoses.

Gerald Stöber1, Julia Sprandel, Burkhard Jabs, Bruno Pfuhlmann, Kerstin Möller-Ehrlich, Michael Knapp.   

Abstract

The dopamine hypothesis of schizophrenia proposes an inherited or acquired presynaptic hyperactivity of dopaminergic neurons. The human dopamine transporter gene (hSLC6A3; hDAT) represents one major mechanism for the termination of dopaminergic neurotransmission. This study examines the degree of genetic association of the 5'-untranslated region (5'-UTR) of the hSLC6A3 to schizophrenia in a family-based association design. Five single nucleotide polymorphisms (SNPs) derived by a previous systematic mutation scan approximately 1.2 kb of the 5'-UTR of the hSLC6A3 locus were genotyped for transmission disequilibrium between 82 index cases (56 males) with schizophrenia and their biological parents. We observed no preferential transmission of alleles from heterozygous parents to affected offspring. Five estimated haplotypes accounted for a frequency of 90% in the index cases, and were identical in cases and non-transmitted parental control haplotypes. Distinct five-locus-genotypes accumulated in schizophrenia compared to parental controls at P-value 0.0038 with odds-ratio of 2.02 (95% CI 0.99-4.14). In conclusion, our present findings support the genetic involvement of distinct hSLC6A3 genotypes in schizophrenia. We propose replication in extended samples and examination of the functional relevance of the associated genotypes on human dopamine transporter expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783497     DOI: 10.1007/s00406-006-0657-3

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  42 in total

1.  Transmission/disequilibrium tests using multiple tightly linked markers.

Authors:  H Zhao; S Zhang; K R Merikangas; M Trixler; D B Wildenauer; F Sun; K K Kidd
Journal:  Am J Hum Genet       Date:  2000-08-31       Impact factor: 11.025

Review 2.  The current status of the dopamine hypothesis of schizophrenia.

Authors:  A Carlsson
Journal:  Neuropsychopharmacology       Date:  1988-09       Impact factor: 7.853

3.  Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II.

Authors:  W S Dynan; R Tjian
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

4.  Antipsychotics and dopamine transporter gene polymorphisms in delirium patients.

Authors:  Jee-Yeon Kim; In-Kwa Jung; Changsu Han; Sook-Haeng Cho; Leen Kim; Seung-Hyun Kim; Bun-Hee Lee; Heon-Jeong Lee; Yong-Ku Kim
Journal:  Psychiatry Clin Neurosci       Date:  2005-04       Impact factor: 5.188

5.  Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations.

Authors:  D J Vandenbergh; M D Thompson; E H Cook; E Bendahhou; T Nguyen; M D Krasowski; D Zarrabian; D Comings; E M Sellers; R F Tyndale; S R George; B F O'Dowd; G R Uhl
Journal:  Mol Psychiatry       Date:  2000-05       Impact factor: 15.992

6.  Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1).

Authors:  F Grünhage; T G Schulze; D J Müller; M Lanczik; E Franzek; M Albus; M Borrmann-Hassenbach; M Knapp; S Cichon; W Maier; M Rietschel; P Propping; M M Nöthen
Journal:  Mol Psychiatry       Date:  2000-05       Impact factor: 15.992

7.  Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples.

Authors:  T A Greenwood; N J Schork; E Eskin; J R Kelsoe
Journal:  Mol Psychiatry       Date:  2006-02       Impact factor: 15.992

8.  Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: family-based association study in the Bulgarian population.

Authors:  L Georgieva; A Dimitrova; I Nikolov; S Koleva; R Tsvetkova; M J Owen; D Toncheva; G Kirov
Journal:  Acta Psychiatr Scand       Date:  2002-05       Impact factor: 6.392

9.  Association of the dopamine transporter gene (DAT1) core promoter polymorphism -67T variant with schizophrenia.

Authors:  N Khodayari; M Garshasbi; F Fadai; A Rahimi; L Hafizi; A Ebrahimi; H Najmabadi; Mina Ohadi
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-08-15       Impact factor: 3.568

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  10 in total

1.  Lack of association between the -839C/T polymorphism in the SLC6A3 gene promoter and schizophrenia in the Iranian population.

Authors:  Hamid Galehdari; Shiva Hosseini; Ali Mohammad Foroughmand; Mohsen Musaviun; Saeedreza Khatami; Atefeh Pooryasin; Tahereh Ajam; Maryam Haidari
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 2.  Positive Traits in the Bipolar Spectrum: The Space between Madness and Genius.

Authors:  Tiffany A Greenwood
Journal:  Mol Neuropsychiatry       Date:  2016-12-09

3.  Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults.

Authors:  Lucas A de Azeredo; Diego L Rovaris; Nina R Mota; Evelise R Polina; Francine Z Marques; Verônica Contini; Eduardo S Vitola; Paulo Belmonte-de-Abreu; Luis A Rohde; Eugenio H Grevet; Claiton H D Bau
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-02-01       Impact factor: 5.270

4.  Ventral midbrain correlation between genetic variation and expression of the dopamine transporter gene in cocaine-abusing versus non-abusing subjects.

Authors:  Yanhong Zhou; Sharon K Michelhaugh; Carl J Schmidt; Jun S Liu; Michael J Bannon; Zhicheng Lin
Journal:  Addict Biol       Date:  2011-10-26       Impact factor: 4.280

Review 5.  Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study.

Authors:  Tiffany A Greenwood; Laura C Lazzeroni; Monica E Calkins; Robert Freedman; Michael F Green; Raquel E Gur; Ruben C Gur; Gregory A Light; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Catherine A Sugar; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; David L Braff
Journal:  Schizophr Res       Date:  2015-11-18       Impact factor: 4.939

6.  Increased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean Cohorts.

Authors:  James L Kennedy; Nian Xiong; Jinlong Yu; Clement C Zai; Jennie G Pouget; Jie Li; Kefu Liu; Hong Qing; Tao Wang; Eden Martin; Deborah L Levy; Zhicheng Lin
Journal:  Schizophr Bull       Date:  2015-12-26       Impact factor: 9.306

7.  A network of dopaminergic gene variations implicated as risk factors for schizophrenia.

Authors:  Michael E Talkowski; George Kirov; Mikhil Bamne; Lyudmila Georgieva; Gonzalo Torres; Hader Mansour; Kodavali V Chowdari; Vihra Milanova; Joel Wood; Lora McClain; Konasale Prasad; Brian Shirts; Jianping Zhang; Michael C O'Donovan; Michael J Owen; Bernie Devlin; Vishwajit L Nimgaonkar
Journal:  Hum Mol Genet       Date:  2007-11-27       Impact factor: 6.150

8.  Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.

Authors:  Tiffany A Greenwood; Neal R Swerdlow; Raquel E Gur; Kristin S Cadenhead; Monica E Calkins; Dorcas J Dobie; Robert Freedman; Michael F Green; Ruben C Gur; Laura C Lazzeroni; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Amrita Ray; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Catherine A Sugar; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Gregory A Light; David L Braff
Journal:  Am J Psychiatry       Date:  2013-05       Impact factor: 18.112

9.  Association analyses reveal gender-specific associations of DAT1 40-bp VNTR and -839C/T polymorphisms with obsessive-compulsive disorder and obsessive-compulsive symptoms.

Authors:  Juliana C Cotrin; Leonardo F Fontenelle; Fabiana B Kohlrausch
Journal:  Mol Biol Rep       Date:  2019-07-19       Impact factor: 2.316

10.  Lack of association between the G-660C polymorphism in the dopamine transporter gene (SLC6A3) and schizophrenia in the Iranian population.

Authors:  Ali M Foroughmand; Hamid Galehdari; Bentalhoda Tirband Dastgerdi; Saeed Reza Khatami; Maryam Haidari
Journal:  Indian J Hum Genet       Date:  2012-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.